Clinical Trial Update: Effect of Weight and/or Obesity on Caspofungin Drug Concentrations [Phase 4]

View source ↗

Summary

Phase 4 study assessing how weight and obesity influence caspofungin drug concentrations; results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Candidiasis

Drugs mentioned

• Caspofungin (caspofungin)

Snippet

Sponsor: Texas Tech University Health Sciences Center | Conditions: Obesity, Fungal Infection | Phase 4 | Status: COMPLETED | Results posted: 2013-01-21